4basebio PLC (FRA:88Q)

Germany · Delayed Price · Currency is EUR

6.40

0.00 (0.00%)

Feb 23, 2026, 9:55 AM CET

Revenue by Segment

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology (Startups)	933.00K	506.00K	268.00K	338.00K	462.00K
Biotechnology (Startups) Growth	84.39%	88.81%	-20.71%	-26.84%	-42.82%
Total	933.00K	506.00K	268.00K	338.00K	462.00K
Total Growth	84.39%	88.81%	-20.71%	-26.84%	-42.82%

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Europe	354.00K	176.00K	85.00K	82.00K	115.00K
Europe Growth	101.14%	107.06%	3.66%	-28.70%	-74.33%
USA	561.00K	320.00K	162.00K	235.00K	347.00K
USA Growth	75.31%	97.53%	-31.06%	-32.28%	-3.61%
Rest of World	18.00K	10.00K	21.00K	21.00K	-
Rest of World Growth	80.00%	-52.38%	0%	-	-
Total	933.00K	506.00K	268.00K	338.00K	462.00K
Total Growth	84.39%	88.81%	-20.71%	-26.84%	-42.82%

Source: S&P Global Market Intelligence.